RFP | February 4, 2014
U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse announces the availability of funding for implementation of the Neuroimmune Signaling and Function in Substance Use Disorders (R01) Grant. The purpose of this grant is to address the identification, characterization, and cellular responses of neuroimmune factors released from glial cells. Contractors should refer to Section VII, Agency Contacts, in the RFP for information regarding each Institute's grants management contact for this program . . .